Skip to content
Review

Peripheral blood glutamate, glutamine, and GABA in Autism Spectrum disorder: A systematic review and meta-analysis of group differences with an exploratory assessment of diagnostic accuracy.

Sep 2026 · Progress in Neuro-psychopharmacology and Biological Psychiatry · Vol 150, pp. 111926 · 0 citations · 85 references
Medicine

TL;DR

The diagnostic analyses yielded exploratory marginal pooled estimates of sensitivity and specificity for GABA and Glu and study-specific estimates for the remaining biomarkers, without establishing overall diagnostic accuracy.

Abstract

Objective

To compare the levels of glutamate (Glu), glutamine (Gln), and γ-aminobutyric acid (GABA) in the blood, as well as the Glu/GABA ratio, between individuals with autism spectrum disorder (ASD) and the general population; and to conduct an exploratory assessment of the discriminatory ability of peripheral blood Glu, GABA, Gln, and related ratios in distinguishing between diagnosed ASD cases and healthy or typically developing controls.

Methods

A systematic search of PubMed, Web of Science, and Embase was performed. Cohort and case-control studies were eligible, and reporting followed PRISMA guidelines. Group differences were summarized as standardized mean differences (SMDs) with 95% confidence intervals. Diagnostic data were analyzed separately by biomarker. Because hierarchical bivariate models did not provide stable estimates, sensitivity and specificity for GABA and Glu were pooled separately using univariate random-effects meta-analyses and interpreted as exploratory marginal pooled estimates. Biomarkers represented by fewer than three datasets were reported descriptively. QUADAS-2 was used to assess the risk of bias in diagnostic-accuracy studies, and GRADE was used to assess the certainty of evidence.

Results

A total of 21 publications were included. 20 publications contributed 29 biomarker-specific group-comparison datasets, and 5 publications contributed 10 biomarker-specific diagnostic-accuracy datasets; four publications contributed to both analyses. The reported sample totals comprised 804 participants with ASD and 721 comparison participants. Compared with the control group, the ASD group had higher peripheral blood Glu levels (SMD = 1.04, 95% CI: 0.62-1.45, P < 0.001;95% PI: -2.109-4.439); no statistically significant difference was observed in peripheral blood GABA levels (SMD = 0.90, 95% CI: -1.03-2.83, P = 0.36; 95% PI: -8.471-10.272). Furthermore, there was extremely high heterogeneity among the studies, and the direction of effect was inconsistent across different studies. Peripheral blood Gln levels were lower in the ASD group (SMD = -0.78, 95% CI: -1.19 ~ -0.37, P < 0.001;95% PI: -2.439-0.881). Two studies suggested that the Glu/GABA ratio in peripheral blood may be reduced in the ASD group; however, the current evidence is insufficient to perform a reliable quantitative meta-analysis or draw definitive conclusions. Five publications contributed 10 biomarker-specific diagnostic-accuracy datasets, including 3 for GABA, 4 for Glu, and 1 each for Gln, the Glu/GABA ratio, and the Glu/Gln ratio. For GABA, exploratory marginal pooled sensitivity and specificity were 0.90 (95% CI: 0.77-0.99) and 0.89 (95% CI: 0.70-1.00), respectively. The corresponding estimates for Glu were 0.68 (95% CI: 0.28-0.97) and 0.78 (95% CI, 0.61-0.91). For Gln, the Glu/GABA ratio, and the Glu/Gln ratio, only a single study was available, so no quantitative pooling was performed. The certainty of the GRADE evidence for all indicators was very low.

Conclusion

The diagnostic analyses yielded exploratory marginal pooled estimates of sensitivity and specificity for GABA and Glu and study-specific estimates for the remaining biomarkers, without establishing overall diagnostic accuracy. However, due to the limited number of included studies, potential selection and spectrum biases inherent in case-control designs, inconsistencies in threshold values across studies, and very low certainty of the evidence, there is currently insufficient evidence to support their use in general-population screening or clinical diagnosis.

View source

Similar papers

Review Oct 2026

Blood zinc and copper levels in children with autism spectrum disorder: a systematic review and meta-analysis

Abstract Background and aims Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition shaped by genetic, environmental, and biochemical influences. Among these, trace elements such as zinc (Zn) and copper (Cu) have attracted considerable interest due to their involvement in synaptic transmission, a...

Mahdi Kashanian, Zohreh Manoochehri, O. Davarinejad et al. · 0 citations
Review Open access Sep 2026

Modulation of GABA and Glutamate by Ketamine in Depression: A Systematic Review and Meta-Analysis of Magnetic Resonance Spectroscopy Studies

Rigorous RCTs with standardized protocols, larger sample sizes, uniform dosing, and systematic biomarker investigations are needed to clarify ketamine’s neurochemical mechanism and optimize ketamine’s clinical application in treatment-resistant depression.

Balwinder Singh, Hossam M. Ali, Alessandro Miola et al. · 0 citations
Meta-analysis Open access Sep 2026

Circulating BDNF in pediatric neurodevelopmental disorders: a meta-analysis of case–control differences and cognitive severity

Background Brain-derived neurotrophic factor (BDNF) has been proposed as a neuroimmune biomarker of cognitive dysfunction in paediatric neurodevelopmental disorders other than autism spectrum disorder, but two related questions remain poorly characterised: whether circulating BDNF differs between affected and unaffecte...

Begüm Çapa Tayyare, B. Yuksel, Nurullah Eryilmaz · 1 citation
Meta-analysis Open access Oct 2026

Serum ferritin in children with Attention Deficit Hyperactivity Disorder (ADHD): A systematic review and meta-analysis

Background Attention-deficit/hyperactivity disorder (ADHD) is a common childhood neurodevelopmental disorder of uncertain etiology. Iron is crucial for brain function and dopamine regulation, but prior studies examining its association with ADHD have produced inconsistent results. This systematic review and meta-analys...

Solomon Gedfie, Muluken Gashaw, Abebe Adisu et al. · 0 citations
Sep 2026

Correlations between cerebrospinal fluid and plasma levels of GABA, glutamate, dopamine, and related metabolites, and their concentrations across neurological disorders.

BACKGROUND Neurotransmitters play critical roles in both central and peripheral nervous system function. However, the correlation between cerebrospinal fluid (CSF) and plasma levels of neurotransmitters remains incompletely understood, limiting the interpretation of peripheral measurements as surrogates for central neu...

Yu-Hang Deng, Wen-Qing Wu, Su-Hyun Han et al. · 0 citations
Sep 2026

Serum vitamin D status is associated with prefrontal excitation-inhibition balance and functional connectivity in preschool children with autism spectrum disorder.

Purpose This study aimed to examine the associations of serum vitamin D status with medial prefrontal cortex (mPFC) neurochemistry, mPFC-centered functional connectivity, and developmental functioning in preschool children with autism spectrum disorder (ASD). Methods A total of 244 children with ASD aged 24-72 months w...

Xiao-Na Zhu, Pu Tian, Liang-Jie Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.